{"product_id":"9783319835310","title":"Resistance to Targeted Anti-Cancer Therapeutics","description":"\u003ch1\u003eResistance to Targeted Anti-Cancer Therapeutics\u003c\/h1\u003e \u003ch2\u003eTivnan, Amanda\u003c\/h2\u003e \u003cp\u003e\u003c\/p\u003e\u003cp\u003eThis  volume will bring together a review of research being carried out by  international experts in this field, detailing treatment  and research approaches in several forms of malignant brain tumors.  These include glioblastoma (GBM), a highly aggressive and fatal form of  astrocytoma which accounts for 80% of newly diagnosed brain tumor  patients per year, and meningioma, of which 10% are  malignant and extremely resistant to targeted therapies. The volume  will also include a discussion of methods to overcome blood-brain  barrier exclusion for more efficient targeted drug delivery in all forms  of brain cancer treatment. The volume will include  information on the repurposing of drugs in an attempt to circumvent  drug resistance, use of small molecule inhibitors in GBM treatment,  mechanisms of secondary brain metastasis, drug resistance, and  state-of-the-art imaging of targeted therapies.\u003cbr\u003e\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2018-07-04\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9783319835310\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-3-319-46505-0\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 260\u003c\/p\u003e ","brand":"Springer International Publishing","offers":[{"title":"Default Title","offer_id":44395441488012,"sku":"9783319835310","price":152.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783319835310.jpg?v=1770822009","url":"https:\/\/lateknightbooks.com\/products\/9783319835310","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}